Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E23.79 EPS (ttm)1.67 Insider Own0.04% Shs Outstand5.58B Perf Week-0.70%
Market Cap219.22B Forward P/E11.65 EPS next Y3.41 Insider Trans-0.12% Shs Float5.57B Perf Month6.81%
Income9.40B PEG1.69 EPS next Q1.00 Inst Own67.60% Short Float1.04% Perf Quarter14.25%
Sales46.41B P/S4.72 EPS this Y-33.10% Inst Trans0.04% Short Ratio1.89 Perf Half Y6.84%
Book/sh11.71 P/B3.39 EPS next Y-10.37% ROA5.10% Target Price40.84 Perf Year12.10%
Cash/sh2.21 P/C17.94 EPS next 5Y14.10% ROE13.40% 52W Range29.96 - 43.08 Perf YTD7.82%
Dividend1.56 P/FCF104.89 EPS past 5Y2.20% ROI7.60% 52W High-7.87% Beta0.72
Dividend %3.93% Quick Ratio1.00 Sales past 5Y-3.00% Gross Margin91.00% 52W Low32.49% ATR0.80
Employees78500 Current Ratio1.40 Sales Q/Q11.80% Oper. Margin12.30% RSI (14)62.85 Volatility2.08% 1.81%
OptionableYes Debt/Eq0.63 EPS Q/Q125.10% Profit Margin18.60% Rel Volume0.85 Prev Close39.35
ShortableYes LT Debt/Eq0.59 EarningsMay 04 BMO Payout96.50% Avg Volume30.75M Price39.69
Recom2.60 SMA201.89% SMA507.48% SMA2009.47% Volume26,208,608 Change0.86%
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
May-13-21 07:00AM  
06:56AM  
06:33AM  
06:28AM  
06:00AM  
05:52AM  
05:34AM  
03:36AM  
May-12-21 09:01PM  
07:32PM  
06:52PM  
06:30PM  
05:40PM  
05:37PM  
04:48PM  
03:47PM  
03:23PM  
02:14PM  
01:30PM  
01:24PM  
01:14PM  
11:05AM  
08:01AM  
06:30AM  
06:16AM  
06:00AM  
05:55AM  
04:01AM  
04:00AM  
May-11-21 08:54PM  
08:40PM  
08:05PM  
08:00PM  
07:28PM  
05:26PM  
05:24PM  
05:12PM  
02:24PM  
02:17PM  
02:09PM  
11:48AM  
11:40AM  
11:30AM  
10:51AM  
10:49AM  
09:56AM  
08:03AM  
06:23AM  
05:23AM  
May-10-21 09:02PM  
08:31PM  
08:00PM  
06:04PM  
05:35PM  
05:24PM  
05:23PM  
05:14PM  
04:44PM  
02:48PM  
01:53PM  
12:23PM  
11:58AM  
11:58AM  
11:40AM  
11:07AM  
10:58AM  
10:51AM  
10:21AM  
10:12AM  
09:35AM  
09:25AM  
08:49AM  
08:21AM  
07:16AM  
06:50AM  
05:52AM  
05:29AM  
05:15AM  
04:00AM  
May-09-21 06:29PM  
03:31PM  
08:27AM  
07:34AM  
May-08-21 08:00PM  
04:44PM  
04:22PM  
01:46PM  
11:48AM  
07:01AM  
06:20AM  
06:04AM  
04:55AM  
04:33AM  
May-07-21 07:40PM  
06:18PM  
06:01PM  
05:00PM  
04:30PM  
04:27PM  
04:06PM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5413,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM